SCHEMBL4540199

SCHEMBL4540199

O=C(NO)C(Oc1ccccc1F)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
PPARG P37231 3/20 0.50
PPARA Q07869 3/20 0.50
GAA P10253 2/20 0.50
HDAC7 Q8WUI4 3/20 0.47
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
KMT2A Q03164 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881179 0.83 PPARA (0.68) ALDH1A1PPARGPPARAGAALMNA
SCHEMBL4536701 0.81 MMP8 (0.48) PPARAHDAC7HDAC3HDAC4HDAC1
SCHEMBL4534368 0.81 ALDH1A1 (0.50) ALDH1A1GAAHDAC7HDAC3HDAC4
SCHEMBL4526444 0.81 KMT2A (0.51) ALDH1A1PPARGPPARAGAAHDAC7
SCHEMBL4533785 0.81 KMT2A (0.53) ALDH1A1HDAC7HDAC3HDAC4HDAC1
SCHEMBL4541582 0.81 HDAC4 (0.49) ALDH1A1PPARGPPARAGAAHDAC7
SCHEMBL17968476 0.81 PPARG (0.52) ALDH1A1PPARGPPARAGAALMNA
SCHEMBL8114217 0.81 PPARG (0.50) ALDH1A1PPARGPPARAGAAHDAC7
SCHEMBL4536114 0.80 PPARG (0.50) ALDH1A1PPARGPPARAHDAC7HDAC3
SCHEMBL4561616 0.80 HDAC7 (0.46) ALDH1A1HDAC7HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 ALDH1A1 532/4885PPARG 1729/4885PPARA 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.